glp 1 pharmaceuticals GLP-1 Drugs and The Pharma Supply Chain GLP-1 Costs Explained: Managing Coverage

Theriogenology (2013) 80(7):8218

As part of a broader, integrated approach to pediatric obesity care, GLP-1 RAs may offer important benefits for carefully selected adolescents, provided their use is supported by rigorous clinical oversight

There may be cases in which the CBE does not recommend a measure to move forward to the rulemaking process and eventual implementation due to a measure not being endorsed by the CBE or other CBE, but we go forth with proposing a measure

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported in JAMA Network Open

Read more about individual peptides and their benefits on our blog